NCT06058065

Sensitivity and Specificity of Xpert MTB/RIF Ultra

Name: Clinical Trial NCT06058065
Creator: Assiut University
Keywords: Tuberculosis, clinical trial

Value of Xpert® MTB/RIF Ultra in Cases With Suspected Tuberculosis

Assiut University·ClinicalTrials.govNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Tuberculosis
Study type: Observational

Sponsor & location

Primary sponsor: Assiut University

Timeline & enrollment

Phase: N/A
Start date: Dec 11, 2023
End date: Dec 25, 2024
Enrollment: 200 participants

Primary outcome

Sensitivity and Specificity of Xpert MTB/RIF Ultra

Summary

To estimate diagnostic accuracy of Xpert Ultra and Xpert MTB/RIF for extrapulmonary tuberculosis and rifampicin resistance in adults suspected to be infected with mycobacterium tuberculosis. In addition, this study will estimate the pattern of rifampicin resistance among TB cases in Assiut population.

ICD-10 classifications

TuberculosisLatent tuberculosisTuberculosis of other organsCongenital tuberculosisSequelae of tuberculosis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06058065
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06058065 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Tuberculosis. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.